.png){kind=icon}
Return
Evolution-guided Bayesian optimization for constrained multi-objective optimization in self-driving labs
.png){kind=icon}
OA
AI
DOI：10.1038/s41524-024-01274-x.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
The development of automated high-throughput experimental platforms has enabled fast sampling of high-dimensional decision spaces. To reach target properties efficiently, these platforms are increasingly paired with intelligent experimental design. However, current optimizers show limitations in maintaining sufficient exploration/exploitation balance for problems dealing with multiple conflicting objectives and complex constraints. Here, we devise an Evolution-Guided Bayesian Optimization (EGBO) algorithm that integrates selection pressure in parallel with a q-Noisy Expected Hypervolume Improvement (qNEHVI) optimizer; this not only solves for the Pareto Front (PF) efficiently but also achieves better coverage of the PF while limiting sampling in the infeasible space. The algorithm is developed together with a custom self-driving lab for seed-mediated silver nanoparticle synthesis, targeting 3 objectives (1) optical properties, (2) fast reaction, and (3) minimal seed usage alongside complex constraints. We demonstrate that, with appropriate constraint handling, EGBO performance improves upon state-of-the-art qNEHVI. Furthermore, across various synthetic multi-objective problems, EGBO shows significative hypervolume improvement, revealing the synergy between selection pressure and the qNEHVI optimizer. We also demonstrate EGBO's good coverage of the PF as well as comparatively better ability to propose feasible solutions. We thus propose EGBO as a general framework for efficiently solving constrained multi-objective problems in high-throughput experimentation platforms.
Keywords:
GAUSSIAN-PROCESSES
Journal
IF:
11.9
Papers:
2.4K
Citations:
1.7W
Organization
Cited Papers
Monoclonal IgM with unique specificity to gangliosides GM
1
and GD
1b
and to lacto‐
N
‐tetraose associated with human motor neuron disease.png)
Neurology
NeurologyIF0
PREAI
ShareSave
ShareSaveShareSaveShareSave
View more